Swara Baby Products SEBI Approval: FirstCry-Backed Hygiene Giant Eyes ₹1,000 Crore IPO

In the latest corporate news live from India's financial sector, Swara Baby Products has officially received approval from the Securities and Exchange Board of India (SEBI) on October 6, 2026, to proceed with a ₹1,000 crore Initial Public Offering (IPO). While many consumers recognize brands like FirstCry or Himalaya, Swara Baby operates as an "invisible giant"—a dominant contract manufacturer that powers the production of disposable hygiene products for some of India's largest wellness and baby care labels [1].

IPO Structure and Financial Split

The proposed ₹1,000 crore public issue is divided equally between new capital generation and promoter exits. According to the draft red herring prospectus (DRHP), the offering consists of a ₹500 crore fresh issue of equity shares and a ₹500 crore Offer for Sale (OFS) [2].

The OFS will see major stakeholders offloading their holdings, specifically Brainbees Solutions (the parent company of FirstCry) selling shares worth ₹300 crore, and Anadya Bon Merchari LLP selling shares worth ₹200 crore [3]. Additionally, the company may pursue a pre-IPO placement of up to ₹100 crore in coordination with its lead managers, JM Financial and Avendus Capital.

Strategic Use of Funds

Swara Baby intends to use the ₹500 crore from the fresh issue to scale its infrastructure and clean up its balance sheet. The primary allocations include:

• Manufacturing Expansion: ₹198.2 crore is earmarked for a new production facility in Madhya Pradesh [2].
• Debt Reduction: A total of ₹127.5 crore will be used to repay borrowings, with ₹100 crore for the main company and ₹27.5 crore allocated to subsidiaries Solis Hygiene, Swara Hygiene, and K.A. Enterprises Hygiene Pvt Ltd (KAEHPL) [3].
• Growth: The remaining proceeds are reserved for general corporate purposes and "inorganic growth" through unidentified acquisitions.

Market Dominance and Financial Health

Founded in 2018 and based in Pithampur and Indore, Swara Baby has rapidly scaled to become a leader in the disposable hygiene space. By FY25, the company held approximately 37% of the baby diaper contract manufacturing market and 36% of the adult diaper contract manufacturing market by value [2].

The company's financial trajectory shows strong momentum. In FY26, operating revenue grew by 23% to ₹1,163.9 crore, up from ₹942.97 crore in FY25. Net profit for the same period stood at ₹95.58 crore, with an EBITDA of ₹192.77 crore [1].

Metric (FY26)	Value
Operating Revenue	₹1,163.9 Crore
Net Profit	₹95.58 Crore
EBITDA	₹192.77 Crore
Baby Diaper Sales Contribution	79% (₹911.81 Crore)

Beyond Contract Manufacturing

While primarily a B2B partner for brands like Piramal Pharma and Himalaya Wellness, Swara Baby also competes in the direct-to-consumer (D2C) market. It operates its own proprietary brands: Cuddles for baby diapers and Shield for adult diapers. The company also expanded into feminine hygiene in December 2025 through the acquisition of KA Enterprises Hygiene Private Ltd [2].